Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Earnings call on financial results for the Quarter and Nine Months ended December 31, 202305-03-2024
05-03-2024
Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for GIC Pvt Ltd29-02-2024
Entero Healthcare Solutions Ltd - 544122 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Friday, March 08, 2024.
Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended December 31, 2023.28-02-2024
Entero Healthcare Solutions Ltd - 544122 - Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Temporarily suspended the drug license of CPD Pharma Private Limited, a wholly owned Subsidiary of the Company, for a period of seven days from 26.02.2024 to 03.03.2024.25-02-2024
Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd23-02-2024
Entero Healthcare Solutions Ltd - 544122 - The Contact Details Of The Key Managerial Personnel ('KMP') Of The Company Pursuant To Regulation 30(5) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
The contact details of the Key Managerial Personnel ("KMP") of the Company pursuant to regulation 30(5) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.20-02-2024
Entero Healthcare Solutions shares close with 9% loss in debut trade
Entero Healthcare Solutions' market valuation stood at Rs 4,999.61 crore on the BSE.17-02-2024
Entero Healthcare Solutions Ltd - 544122 - Closure of Trading Window
Trading window closure notice16-02-2024
Entero Healthcare Solutions Ltd - 544122 - Listing of equity shares of Entero Healthcare Solutions Ltd
Trading Members of the Exchange are hereby informed that effective from February 16, 2024, the equity shares of Entero Healthcare Solutions Ltd (Scrip Code: 544122) are listed and admitted to dealings on the Exchange in the list of ''B'' Group Securities. For further details please refer to the notice no 20240215-36 dated February 15, 2024.16-02-2024
Entero Healthcare Solutions subscribed 1.53 times on final day
Qualified Institutional Buyers portion got subscribed 2.28 times with QIBs bidding for 86.86 lakh shares against the 38.08 lakh shares reserved13-02-2024